Grifols signed a 40 GWh PPA and Grifols stock gained 1.22 percent
Published on 10/09/2026 at 12:32 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWSKey points in brief
- Grifols signed a 40 GWh annual renewable power agreement with Engie for 2027 to 2037.
- First-half 2026 net profit rose 28.70 percent to EUR 227 million, while revenue grew 2.60 percent at constant currency.
- Grifols stock was trading at EUR 9.95 at Lang & Schwarz on October 9, 2026 at 12:30 p.m. CEST, up 1.22 percent versus EUR 9.83.
- The next reported results date is November 10, 2026.
Grifols signed a renewable power purchase agreement covering 40 GWh annually from 2027 to 2037, while Grifols stock was trading at EUR 9.95 at Lang & Schwarz on October 9, 2026 at 12:30 p.m. CEST, up 1.22 percent versus the EUR 9.83 prior close. As Democrata reported on September 16, 2026, the agreement with Engie will supply renewable electricity in Spain between 2027 and 2037.
Three milestones shape the year
On May 7, 2026, Grifols reported first-quarter revenue of EUR 1.7 billion and net profit of EUR 73 million. On July 28, 2026, the company reported first-half revenue of EUR 3.6 billion, up 2.60 percent at constant currency, and net profit of EUR 227 million, up 28.70 percent year over year, according to Grifols.
The September power agreement adds a cost and sourcing angle to the earnings story. Its 40 GWh annual volume is a concrete operating commitment, but the release does not quantify the expected earnings effect.
What does 40 GWh mean for margins?
The first-half financial profile gives investors a measurable benchmark. According to the Yahoo Finance transcript of the July 28, 2026 earnings call, adjusted EBITDA reached EUR 854 million in the first half of 2026, with an adjusted EBITDA margin of 23.90 percent. Management also maintained a full-year 2026 adjusted EBITDA margin target of 25.00 percent or higher.
The comparison matters because the renewable agreement covers a defined energy volume, while the margin target covers the whole group. The public figures therefore support an operating-efficiency discussion, but they do not establish that the PPA itself caused the margin outlook.
Next results date is November 10
Investing.com lists November 10, 2026 as Grifols' next results date. That report will provide the next quantified test of the 2026 margin target, revenue growth and the contribution from the company's plasma and diagnostics businesses.
Grifols stock trades above EUR 9.83
At Lang & Schwarz, Grifols stock was trading at EUR 9.95 on October 9, 2026 at 12:30 p.m. CEST, up 1.22 percent versus the prior close of EUR 9.83 on October 8, 2026. The price direction is positive, while the company-specific evidence remains centered on the 40 GWh agreement and the first-half figures.
The further course of trading is shown by the continuously updated real-time quote of Grifols stock.
Grifols stock at a glance
- Company: Grifols, S.A.
- ISIN: ES0171996087
- Ticker: GRF.MC
- Primary exchange: BME
- Price Lang & Schwarz as of October 9, 2026, 12:30 p.m. CEST: EUR 9.95
- Change versus prior close: plus 1.22 percent
- Prior close Lang & Schwarz October 8, 2026: EUR 9.83
- Sector / Industry: Healthcare / Drug Manufacturers - General
- Index membership: IBEX 35

